Frontiers in Oncology | Hematologic Malignancies

Case Report

Accepted on 14 Jul 2025

Case Report: Reactive T-cell Large Granular Lymphocytes in the Bone Marrow of a Patient with Relapsed/Refractory Multiple Myeloma Receiving Teclistamab

in Hematologic Malignancies

Erin A. Dean
Li-Jun Yang
Robert Seifert
John R Wingard

Frontiers in Oncology

doi 10.3389/fonc.2025.1630929

145 views

Original Research

Accepted on 10 Jul 2025

NAP1L5 in Acute Myeloid Leukemia: A Prognostic Biomarker and Potential Therapeutic Target

in Hematologic Malignancies

Meng Wang
Zhibin Xie
Yuanyuan Tan
Yan Zhou
Tingting Zhang
Yuqing Du
Huan Wu
Lili Zhou
Jiajia Li
Jian Ge

Frontiers in Oncology

doi 10.3389/fonc.2025.1617564

147 views

Original Research

Published on 10 Jul 2025

Patient and physician treatment preferences in relapsed/refractory follicular lymphoma: a discrete choice experiment in the United States, United Kingdom, France, Germany, Brazil, and Japan

in Hematologic Malignancies

John G. Gribben
Emmanuel Bachy
Markqayne Ray
Kathryn Krupsky
Kathleen Beusterien
Lewis Kopenhafer
Sara Beygi
Timothy Best
Graeme Ball
Oliver Will

Frontiers in Oncology

doi 10.3389/fonc.2025.1589722

1,065 views

Original Research

Published on 09 Jul 2025

Efficacy and safety of rituximab-based chemoimmunotherapy in adult patients with Burkitt lymphoma in Korea

in Hematologic Malignancies

Gi-June Min
Ka Young Kim
Tong Yoon Kim
Young-Woo Jeon
Byung-Su Kim
Seung-Ah Yahng
Ki-Seong Eom
Seok-Goo Cho

Frontiers in Oncology

doi 10.3389/fonc.2025.1614506

459 views

Case Report

Published on 09 Jul 2025

Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review

in Hematologic Malignancies

Hongjuan Dong
Rui Wang
Lu Cheng
Shirong Ma
Li Zhu
Jing Zhao
Guangxun Gao

Frontiers in Oncology

doi 10.3389/fonc.2025.1632039

451 views

Original Research

Published on 08 Jul 2025

ZFAS1/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming

in Hematologic Malignancies

Lan Yang
Yanqiu Han

Frontiers in Oncology

doi 10.3389/fonc.2025.1603060

436 views

Case Report

Published on 08 Jul 2025

Isolated relapse of multiple myeloma in the central nervous system post autologous hematopoietic stem cell transplantation: a case report and literature review

in Hematologic Malignancies

Ying Zhou
Qian Shen
Jie Zhang
Li Zhu
Qi Jiang
Xiaobing Miao

Frontiers in Oncology

doi 10.3389/fonc.2025.1628297

218 views

Original Research

Published on 08 Jul 2025

Long-term endocrine outcomes and quality of life in paediatric and young chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy: a prospective study from India

in Hematologic Malignancies

Rajiv Mohan
Chitrakshi Nagpal
Swasthik Upadhya
Akash Kumar
Rajesh Khadgawat
Sameer Bakhshi
Deepam Pushpam

Frontiers in Oncology

doi 10.3389/fonc.2025.1598104

401 views

Original Research

Published on 08 Jul 2025

Observations on seasonal occurrence in lymphomas with proven or presumed infectious etiology

in Hematologic Malignancies

Ioannis Anagnostopoulos
Viktoria Buck
Elena Gerhard-Hartmann
Alberto Zamó
Andreas Rosenwald
Mathias Rosenfeldt
Korinna Jöhrens

Frontiers in Oncology

doi 10.3389/fonc.2025.1586441

310 views

Case Report

Accepted on 07 Jul 2025

A Familial Hematological Pedigree Reveals VHL Germline Mutation as a Principal Predisposition Factor with Additional Mutations Modulating Phenotypic Heterogeneity

in Hematologic Malignancies

Huiling Chen
Wanli Hu
Chengcheng Ma
Miaomiao Zhang
Fuhua Yang
Pengyun Zeng

Frontiers in Oncology

doi 10.3389/fonc.2025.1630715

114 views

Original Research

Accepted on 04 Jul 2025

Disproportionality Analysis of Adverse Events Associated with Pacritinib: A Real-World Study Based on FDA Adverse Event Reporting System (FAERS) Database

in Hematologic Malignancies

Huiling Zhang
Yaping Huang
Chengjie Ke
Maohua Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1618267

169 views

Original Research

Accepted on 04 Jul 2025

Frontline brentuximab vedotin-based therapy for newly diagnosed classical Hodgkin lymphoma: a meta-analysis of randomized controlled trials

in Hematologic Malignancies

Yue Yang
Shurong Liu
Li Wang
Rui Zhang
Jing Xie

Frontiers in Oncology

doi 10.3389/fonc.2025.1636923

169 views

Review

Published on 04 Jul 2025

A deep dive into the surgical and pharmacological considerations of obesity in chronic myeloid leukemia: a narrative review

in Hematologic Malignancies

Rola Ghasoub
Basant Elsayed
Maria Benkhadra
Giuseppe Saglio
Jorge Cortes
Mohamed Elmarasi
Engy Elsayed
Ahmed Adel Elsabagh
Ibrahim Elmakaty
Abdelrahman Elsayed

Frontiers in Oncology

doi 10.3389/fonc.2025.1616883

764 views

Perspective

Accepted on 30 Jun 2025

A Roadmap to Implementing Outpatient Administration of Bispecific Antibodies in Multiple Myeloma

in Hematologic Malignancies

Alfred L. Garfall
Rahul Banerjee
Laurent Frenzel
Cyrus Khandanpour
Yi Lin
Erica Ottoni
Robert Rifkin
Sarah Rockwell
Cesar Rodriguez
Humberto Villefort

Frontiers in Oncology

doi 10.3389/fonc.2025.1630146

221 views

Original Research

Accepted on 27 Jun 2025

Identification and Visualization of Fusion Gene Subtypes in APL Using Spatial Attention Mechanisms in Vision Models

in Hematologic Malignancies

Peirou Yan
Guo Pu
Ping Wu
Lijun Wen
Suning Chen
Song Xue

Frontiers in Oncology

doi 10.3389/fonc.2025.1619296

148 views

Review

Accepted on 27 Jun 2025

Nestin in multiple myeloma: emerging insights into a potential therapeutic target

in Hematologic Malignancies

Yingmiao Wu
Ji Luo
Yue Zhou
Jiaoya Lin
Yajie Wu
Shuai Zheng
Huang Guo
Feifei Che
Qiang Wang
Ling Zhong

Frontiers in Oncology

doi 10.3389/fonc.2025.1596928

101 views